Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1945 studies found for:    "Melanoma"
Show Display Options
Rank Status Study
21 Terminated Imatinib in Adult Patients With Metastatic Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Imatinib
22 Completed Intralesional PV-10 Chemoablation of Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: PV-10 (rose bengal disodium, 10%)
23 Recruiting A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)
Condition: Melanoma
Interventions: Drug: pembrolizumab + epacadostat;   Drug: pembrolizumab + placebo
24 Completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: Histone Deacetylase Inhibitor, MS-275 (BAY 86-5274, ZK 244894)
25 Recruiting In Vivo Real-time Detection of Circulating Melanoma Cells
Condition: Melanoma
26 Terminated Interleukin-2 in Metastatic Melanoma
Condition: Melanoma Metastatic
Intervention: Drug: Interleukin-2
27 Unknown  A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: HyperAcute vaccine;   Drug: Pegylated Interferon-Alpha 2b
28 Withdrawn Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions
Condition: Melanoma
Interventions: Drug: MRX34;   Drug: Dexamethasone
29 Recruiting Treatment of Advanced Melanoma With MK-3475 and Peginterferon
Condition: Melanoma
Interventions: Drug: MK-3475;   Drug: Peginterferon alfa-2b
30 Recruiting BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: BGB324+pembrolizumab;   Drug: BGB324+dabrafenib and trametinib;   Drug: pembrolizumab;   Drug: dabrafenib and trametinib
31 Unknown  Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: ALS-357
32 Recruiting Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Condition: Melanoma
Interventions: Drug: Dabrafenib;   Drug: Trametinib;   Drug: Metformin
33 Unknown  A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma
Condition: Melanoma
Interventions: Drug: imatinib;   Drug: Interferon
34 Completed Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
Condition: Melanoma
Intervention: Drug: TKI258
35 Not yet recruiting SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
Conditions: Melanoma;   Metastatic Melanoma
Interventions: Radiation: SAbR;   Drug: Ipilimumab;   Drug: Nivolumab
36 Completed CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
Condition: Melanoma
Intervention: Drug: CY-503
37 Completed Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
Condition: Melanoma
38 Completed Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
Condition: Melanoma
Intervention: Biological: CYT004-MelQbG10
39 Recruiting A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
Condition: Melanoma
Intervention: Drug: SHR6390
40 Completed Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
Condition: Melanoma
Intervention: Drug: P276-00

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.